Lys-kallidin [4940]
Lys-kallidin
| SMILES | NCCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O |
| InChIKey | PLJGSWAPCHRWMD-CUZNLEPHSA-N |
| Sequence | KKRPPGFSPFR |
| HELM | PEPTIDE1{K.K.R.P.P.G.F.S.P.F.R}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 17 |
| Hydrogen bond donors | 16 |
| Rotatable bonds | 39 |
| Log P | -4.761 |
| Molecular weight (Da) | 1315.8 |
| Stereochemistry info | unspecified |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
Lys-kallidin
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0